Supporting Self-employment in Young Adults with Stroke
Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 12, 2024
Trial Information
Current as of August 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how an 8-week online program can help young adults who have had a stroke to develop skills for self-employment. The program aims to improve not only the chances of these individuals starting their own businesses but also their confidence, overall happiness, and social well-being. Researchers want to see how this intervention can benefit working-age stroke survivors, helping them to regain a sense of purpose and independence.
To qualify for the study, participants should be between 18 and 65 years old, have experienced a stroke, and have been unemployed for at least six months. They also need to be able to communicate in Cantonese and read Traditional Chinese. If you join the trial, you will take part in the skill-building program and share your experiences, which will help researchers understand its effects. This is an exciting opportunity to explore new paths toward employment and personal satisfaction after a stroke!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-65 years old at the time of recruitment
- • been clinically diagnosed with a first-ever/recurrent ischaemic/haemorrhagic stroke
- • a Montreal Cognitive Assessment score (MoCA) \>2nd percentile
- • a paid job (full-time/part-time) at the recent onset of stroke
- • been unemployed (not in paid, full-time/part-time job) for ≥6 months at the time of recruitment
- • able to communicate in Cantonese and read Traditional Chinese.
- Exclusion Criteria:
- • diagnosed with transient ischaemic attack
- • cerebrovascular events due to tumour
- • diagnosed with a mental condition for example depression or schizophrenia
- • incomprehensible speech
- • receiving or awaiting to receive vocational programmes
- • self-employed at the time of recruitment or planning to retire
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Suzanne Lo
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported